79355199

Information

• Trademark
• 79355199

• Source

• Serial Number

  79355199

• Registration Number

  7129133

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  September 28, 2022
  a year ago

• Registration Date

  August 08, 2023
  9 months ago

• Transaction Date

  November 14, 2023
  6 months ago

• Status Date

  August 08, 2023
  9 months ago

• Published for Opposition Date

  May 23, 2023
  a year ago

• Location Date

  August 08, 2023
  9 months ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  EISNACH, MICHAEL PATRI

• Attorney Docket Number

  0332003

  Attorney Name

  M. Scott Alprin

  Law Office Assigned Location Code

  L40

• Owners

  • Nihon Medi-Physics Co., Ltd.

Case File Statements

• GS0401: Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
• DM0000: The mark consists of two wavy lines resembling double-stranded DNA in navy together with three comet-like figures in orange. The white in the mark is background only and is not claimed as a feature of the mark.
• GS0051: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
• CC0000: The color(s) navy and orange is/are claimed as a feature of the mark.
• GS0011: Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
• GS0451: Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights
• GS0421: Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances

Case File Event Statements

• 11/14/2023 - 6 months ago

  25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 11/14/2023 - 6 months ago

  24 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/8/2023 - 6 months ago

  23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/8/2023 - 9 months ago

  22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 8/8/2023 - 9 months ago

  21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/24/2023 - a year ago

  20 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/23/2023 - a year ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/23/2023 - a year ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/3/2023 - a year ago

  17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 5/3/2023 - a year ago

  16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 5/3/2023 - a year ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/19/2023 - a year ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/18/2023 - a year ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/17/2023 - a year ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/17/2023 - a year ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/7/2023 - a year ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 2/15/2023 - a year ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 2/15/2023 - a year ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/20/2022 - a year ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/19/2022 - a year ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/9/2022 - a year ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 11/29/2022 - a year ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 11/23/2022 - a year ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/22/2022 - a year ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 11/17/2022 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR